Study Stopped
Discontinued cystitis study due to poor recruitment. To continue the trial under these circumstances is considered non-viable.
Study to Determine if Hyperbaric Oxygen Therapy is Helpful for Treating Radiation Tissue Injuries
Hyperbaric Oxygen Radiation Tissue Injury Study - Project HORTIS
2 other identifiers
interventional
248
5 countries
7
Brief Summary
The principle objective of this research is to more precisely determine the degree of benefit that hyperbaric oxygen therapy affords in the treatment of late radiation tissue injury. The study has eight\* components. Seven involve the evaluation of established radionecrosis at varying anatomic sites (mandible, larynx, skin, bladder, rectum, colon, and gyn). The eighth will investigate the potential of hyperbaric oxygen (HBO) therapy to prophylax against late radiation tissue injury. \*(One of the arms, HORTIS IV - Proctitis has been closed to further patient recruitment. This decision was based on an interim statistical analysis which generated sufficient evidence to support closing down this arm of HORTIS.)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Jan 2001
Longer than P75 for phase_3
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2001
CompletedFirst Submitted
Initial submission to the registry
August 23, 2005
CompletedFirst Posted
Study publicly available on registry
August 25, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJanuary 12, 2016
February 1, 2012
10.6 years
August 23, 2005
January 11, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
SOMA (Subjective, Objective, Management, Analytic) scale used to determine late effects to normal tissue (LENT) score
pre-treatment, post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years
Secondary Outcomes (6)
Clinical assessment using one of the following criteria:
post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years
Healed
post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years
Modestly improved (< 50% lesion resolution)
post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years
Not improved
post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years
Other (e.g. lesion recurrence, lesion size progression)
post-treatment (HBO and placebo) and at follow ups at 3 months, 6 months, and 1 year through 5 years
- +1 more secondary outcomes
Study Arms (2)
A
ACTIVE COMPARATORHyperbaric Oxygen Therapy
B
SHAM COMPARATORNormal Air
Interventions
Eligibility Criteria
You may qualify if:
- Endarteritis
- Hypovascularity
- Diarrhea
- Cramping
- Obstruction
- Stricture
- Pain
- Hemorrhage
- Wall Changes
- Ulceration
- Hypocellularity
- Mucosal thickening
- Vomiting
- Tenesmus
- Constipation
- +4 more criteria
You may not qualify if:
- Pregnancy
- Reactive airway disease
- Radiographic evidence of pulmonary blebs or bullae
- Untreated pneumothorax
- Previously documented ejection fraction less than 35%
- History of seizures except childhood febrile seizures
- Cardiovascular instability
- Mechanical ventilator support with the exception of those patients who are immediately (1-5 days) post-operative
- Unable to follow simple commands
- Not orientated to person, place, time
- Participating as a subject in any other medical or biomedical research project; if previously involved as a subject, sufficient time must have elapsed to permit "wash out" of any investigational agent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Palmetto Health Richland
Columbia, South Carolina, 29203, United States
Wesley Medical Center
Brisbane, Queensland, 4064, Australia
Royal Hobart Hospital
Hobart, Tasmania, 7001, Australia
Instituto Nacional de Cancerologica
Mexico City, 14080, Mexico
University of Stellenbosch
Cape Town, South Africa
University of Pretoria Medical Center
Pretoria, 0001, South Africa
Istanbul University Medical Center
Istanbul, 34390, Turkey (Türkiye)
Related Publications (10)
Curi MM, Dib LL. Osteoradionecrosis of the jaws: a retrospective study of the background factors and treatment in 104 cases. J Oral Maxillofac Surg. 1997 Jun;55(6):540-4; discussion 545-6. doi: 10.1016/s0278-2391(97)90478-x.
PMID: 9191633BACKGROUNDJoseph DL, Shumrick DL. Risks of head and neck surgery in previously irradiated patients. Arch Otolaryngol. 1973 May;97(5):381-4. doi: 10.1001/archotol.1973.00780010393005. No abstract available.
PMID: 4703530BACKGROUNDSamuels L, Granick MS, Ramasastry S, Solomon MP, Hurwitz D. Reconstruction of radiation-induced chest wall lesions. Ann Plast Surg. 1993 Nov;31(5):399-405. doi: 10.1097/00000637-199311000-00003.
PMID: 8285524BACKGROUNDHart GB, Mainous EG. The treatment of radiation necrosis with hyperbaric oxygen (OHP). Cancer. 1976 Jun;37(6):2580-5. doi: 10.1002/1097-0142(197606)37:63.0.co;2-h.
PMID: 949677BACKGROUNDMarx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983 May;41(5):283-8. doi: 10.1016/0278-2391(83)90294-x.
PMID: 6572704BACKGROUNDMarx RE. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg. 1983 Jun;41(6):351-7. doi: 10.1016/s0278-2391(83)80005-6. No abstract available.
PMID: 6574217BACKGROUNDBevers RF, Bakker DJ, Kurth KH. Hyperbaric oxygen treatment for haemorrhagic radiation cystitis. Lancet. 1995 Sep 23;346(8978):803-5. doi: 10.1016/s0140-6736(95)91620-2.
PMID: 7674746BACKGROUNDWoo TC, Joseph D, Oxer H. Hyperbaric oxygen treatment for radiation proctitis. Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):619-22. doi: 10.1016/s0360-3016(97)00017-5.
PMID: 9231688BACKGROUNDWilliams JA Jr, Clarke D, Dennis WA, Dennis EJ 3rd, Smith ST. The treatment of pelvic soft tissue radiation necrosis with hyperbaric oxygen. Am J Obstet Gynecol. 1992 Aug;167(2):412-5; discussion 415-6. doi: 10.1016/s0002-9378(11)91421-5.
PMID: 1497044BACKGROUNDFeldmeier JJ, Heimbach RD, Davolt DA, Brakora MJ. Hyperbaric oxygen as an adjunctive treatment for severe laryngeal necrosis: a report of nine consecutive cases. Undersea Hyperb Med. 1993 Dec;20(4):329-35.
PMID: 8286987BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dick Clarke, CHT
National Baromedical Services
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- President, National Baromedical Research Foundation
Study Record Dates
First Submitted
August 23, 2005
First Posted
August 25, 2005
Study Start
January 1, 2001
Primary Completion
August 1, 2011
Study Completion
December 1, 2015
Last Updated
January 12, 2016
Record last verified: 2012-02